---
title: "BridgeBio Pharma, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/88635c8c-0adf-560a-a3ee-e2e0ebab90a9
json: https://whiteintel.dev/api/public/dossier/88635c8c-0adf-560a-a3ee-e2e0ebab90a9
identifier: sec:0001743881
jurisdiction: US
risk: High
source: WhiteIntel corporate-ownership graph
---

# BridgeBio Pharma, Inc.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001743881`  
**Risk level:** High  
**Canonical dossier:** https://whiteintel.dev/entity/88635c8c-0adf-560a-a3ee-e2e0ebab90a9  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/88635c8c-0adf-560a-a3ee-e2e0ebab90a9  

## Ownership & control

### Owners / controllers

- **KKR Group Holdings Corp.** (10% owner) — https://whiteintel.dev/entity/982a5d99-be7d-5ab5-b3bb-3feb43aa36a2
- **KKR Genetic Disorder GP LLC** (10% owner) — https://whiteintel.dev/entity/5b47eb3b-2031-564e-abc1-ae66af1a0cd4
- **KRAVIS HENRY R** (10% owner) — https://whiteintel.dev/entity/d4f69568-a82b-54ce-8d32-d56bf8bf176c
- **KKR & Co. Inc.** (10% owner) — https://whiteintel.dev/entity/29527aac-ef67-5541-be36-ce09fc24c121
- **ROBERTS GEORGE R** (10% owner) — https://whiteintel.dev/entity/d0ad010d-ccac-5579-b160-f812392adb8e
- **KKR Group Co. Inc.** (10% owner) — https://whiteintel.dev/entity/6051ac01-3c69-535e-bef9-248836d159e6
- **KKR Genetic Disorder L.P.** (10% owner) — https://whiteintel.dev/entity/2a818e29-4698-5c84-8e15-434471d88007
- **KKR Management LLP** (10% owner) — https://whiteintel.dev/entity/3bda6c73-72cd-53a1-b392-5de72e74ec70
- **KKR Group Partnership L.P.** (10% owner) — https://whiteintel.dev/entity/d8e0d170-2e92-5c0c-8895-e6d2fe0c740d
- **Viking Global Opportunities Illiquid Investments Sub-Master LP** (10% owner) — https://whiteintel.dev/entity/ee220400-cba6-5671-9078-6ccf703cfa18
- **Ott David C.** (10% owner) — https://whiteintel.dev/entity/dfcc9579-6ff0-5352-8744-07cf912e06ca
- **Viking Global Opportunities Portfolio GP LLC** (10% owner) — https://whiteintel.dev/entity/d7077b05-1daa-55a8-823f-d5e6364224ae
- **Shabet Rose Sharon** (10% owner) — https://whiteintel.dev/entity/2b099c36-1f6c-5a07-9125-16cb906b6e5e
- **HALVORSEN OLE ANDREAS** (10% owner) — https://whiteintel.dev/entity/3c33a7f9-c886-53fd-b423-88dd348a7c25
- **Viking Global Opportunities Parent GP LLC** (10% owner) — https://whiteintel.dev/entity/6726d229-f953-5379-b2c3-96850d22e48b
- **VIKING GLOBAL INVESTORS LP** (10% owner) — https://whiteintel.dev/entity/d3582384-b62b-51ce-bd33-b887d892fc33
- **Viking Global Opportunities GP LLC** (10% owner) — https://whiteintel.dev/entity/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95
- **HALVORSEN OLE ANDREAS** (tenpercentowner) — https://whiteintel.dev/entity/3c33a7f9-c886-53fd-b423-88dd348a7c25
- **Viking Global Opportunities Portfolio GP LLC** (tenpercentowner) — https://whiteintel.dev/entity/d7077b05-1daa-55a8-823f-d5e6364224ae
- **Ott David C.** (tenpercentowner) — https://whiteintel.dev/entity/dfcc9579-6ff0-5352-8744-07cf912e06ca
- **Viking Global Opportunities GP LLC** (tenpercentowner) — https://whiteintel.dev/entity/2d1b1af6-e62e-5904-ae1b-c3d2b947ed95
- **Viking Global Opportunities Illiquid Investments Sub-Master LP** (tenpercentowner) — https://whiteintel.dev/entity/ee220400-cba6-5671-9078-6ccf703cfa18
- **VIKING GLOBAL INVESTORS LP** (tenpercentowner) — https://whiteintel.dev/entity/d3582384-b62b-51ce-bd33-b887d892fc33
- **Viking Global Opportunities Parent GP LLC** (tenpercentowner) — https://whiteintel.dev/entity/6726d229-f953-5379-b2c3-96850d22e48b
- **Shabet Rose Sharon** (tenpercentowner) — https://whiteintel.dev/entity/2b099c36-1f6c-5a07-9125-16cb906b6e5e
- **ROBERTS GEORGE R** (tenpercentowner) — https://whiteintel.dev/entity/d0ad010d-ccac-5579-b160-f812392adb8e
- **KKR Group Partnership L.P.** (tenpercentowner) — https://whiteintel.dev/entity/d8e0d170-2e92-5c0c-8895-e6d2fe0c740d
- **KKR Management LLP** (tenpercentowner) — https://whiteintel.dev/entity/3bda6c73-72cd-53a1-b392-5de72e74ec70
- **KRAVIS HENRY R** (tenpercentowner) — https://whiteintel.dev/entity/d4f69568-a82b-54ce-8d32-d56bf8bf176c
- **KKR Group Holdings Corp.** (tenpercentowner) — https://whiteintel.dev/entity/982a5d99-be7d-5ab5-b3bb-3feb43aa36a2
- **KKR Group Co. Inc.** (tenpercentowner) — https://whiteintel.dev/entity/6051ac01-3c69-535e-bef9-248836d159e6
- **KKR & Co. Inc.** (tenpercentowner) — https://whiteintel.dev/entity/29527aac-ef67-5541-be36-ce09fc24c121
- **KKR Genetic Disorder GP LLC** (tenpercentowner) — https://whiteintel.dev/entity/5b47eb3b-2031-564e-abc1-ae66af1a0cd4
- **KKR Genetic Disorder L.P.** (tenpercentowner) — https://whiteintel.dev/entity/2a818e29-4698-5c84-8e15-434471d88007
- **SATVAT ALI J.** (tenpercentowner) — https://whiteintel.dev/entity/60aed33f-4fa3-5322-8b5c-e46c85052b49
- **KKR MANAGEMENT HOLDINGS L.P.** (tenpercentowner) — https://whiteintel.dev/entity/2c029593-52c0-5945-8fa9-4cc694551a58
- **KKR MANAGEMENT HOLDINGS CORP** (tenpercentowner) — https://whiteintel.dev/entity/cfa57ebf-5d33-59b9-8b6f-a31a8f64b87e
- **MOMTAZEE JAMES C** (tenpercentowner) — https://whiteintel.dev/entity/90f0425f-414a-5d65-bec5-e16c6ef24bba
- **VIKING LONG FUND GP LLC** (tenpercentowner) — https://whiteintel.dev/entity/d1047e67-0276-5b53-aec3-a26b6b090b86
- **VIKING LONG FUND MASTER LTD.** (tenpercentowner) — https://whiteintel.dev/entity/20c9f70f-61d2-5905-8e27-c93fc598c901
- **VIKING GLOBAL PERFORMANC LLC** (tenpercentowner) — https://whiteintel.dev/entity/f3af5bce-c85e-5dc7-904b-baca5aa99884
- **VIKING GLOBAL EQUITIES MASTER LTD.** (tenpercentowner) — https://whiteintel.dev/entity/039e1bf1-f951-5c55-9dcb-aee410f9f700

### Holdings / subsidiaries

- **Helix Acquisition Corp. II** (tenpercentowner) — https://whiteintel.dev/entity/951d662b-64f7-505f-89fe-a8511d9ab55a
- **EIDOS THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/acbd6646-3115-5a14-9bb7-ae9f6a90f8fd

### UBO chain (walk to the ultimate owner)

A **130-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BridgeBio Pharma, Inc.**. Human view: https://whiteintel.dev/entity/88635c8c-0adf-560a-a3ee-e2e0ebab90a9 · Structured JSON: https://whiteintel.dev/api/public/dossier/88635c8c-0adf-560a-a3ee-e2e0ebab90a9._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._